May 21, 2013 12:00PM Transgene Announces Completion of Enrollment in TRAVERSE, a Phase 2b Clinical Trial of Pexa-Vec for the Treatment of Liver Cancer
May 21, 2013 10:24AM Transgene Announces its Invesment in ElsaLys Biotech, a New Antibody Company Created by Former Executives
May 21, 2013 10:00AM Russell Reynolds Associates Adds Sofie Qiao to San Francisco Office and Max Zuckerman to the Palo Alto Office
May 21, 2013 08:15AM Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine
May 21, 2013 02:00AM Sanofi Relies on Axway to Future-Proof their Infrastructure and Reduce Operational Costs through Global Consolidation
May 20, 2013 09:40AM 89 Degrees Names Bill Peña Vice President of Technology Services
May 17, 2013 08:00AM Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis
May 17, 2013 02:00AM The start-up ElsaLys Biotech, a new player in the therapeutic monoclonal antibody arena, announces the first round of financing with Transgene and Sofimac Partners
May 15, 2013 08:30AM OvaScience Reports First Quarter Fiscal 2013 Financial Results
May 15, 2013 01:00AM Sanofi and Regeneron Announce Patient Enrollment in Two Phase 3 Trials with Sarilumab in Rheumatoid Arthritis (RA)
May 14, 2013 08:00AM Third Rock Ventures Expands and Strengthens Team
May 6, 2013 08:18AM Parkinson's Therapeutics Reviewed by NeuroPerspective
May 2, 2013 07:00AM Sanofi: Q1 2013 business EPS(1) impacted by exclusivity losses in prior year
May 1, 2013 03:05PM First Manhattan Files Preliminary Proxy Materials with SEC for the Election of Six Directors to Vivus’ Board at the 2013 Annual Meeting
Apr 30, 2013 08:00AM NextBio Announces Translational Medicine Partnership with Sanofi
Apr 30, 2013 07:30AM Henri A. Termeer Joins Moderna Therapeutics Board Of Directors
Apr 29, 2013 08:45AM Burrill Securities Launches Institutional Breakthrough Series
Apr 29, 2013 01:45AM Transgene: Promising Final Data from the Phase 2 HCVac Trial of TG4040 Presented at EASL 2013
Apr 29, 2013 01:45AM Transgene Presents Promising Pre-Clinical Data on TG1050 to Treat Chronic HBV at EASL 2013
Apr 25, 2013 09:00AM J.D. Power and Associates Reports: Evidence that Relationship Marketing Still Matters in Oncology Pharmaceutical Sales
Apr 25, 2013 01:00AM Once-daily AUBAGIO® Delayed Onset of Clinically Definite Multiple Sclerosis (MS) in TOPIC Study
Apr 23, 2013 08:00AM CEL-SCI Corporation Provides Update on Phase III Clinical Trial
Apr 23, 2013 08:00AM U.S. FDA Grants Fast-Track Designation to Sanofi Pasteur and KaloBios' Novel Biologic Candidate for Pseudomonas aeruginosa
Apr 22, 2013 11:45AM Transgene : First Quarter 2013 Financial Report
Apr 22, 2013 08:00AM 89 Degrees: Overview of US Loyalty Programs
Apr 18, 2013 04:00PM Cubist Pharmaceuticals Reports First Quarter 2013 Financial Results
Apr 18, 2013 08:00AM Genzyme Convenes 13th European Fabry Disease Roundtable
Apr 17, 2013 08:15AM Veracyte Announces That New Study Suggests The Number Of Patients At Risk For Unnecessary Thyroid Surgery Is Likely On The Rise
Apr 12, 2013 08:15AM Veracyte Announces Appointment of Shelly D. Guyer as Chief Financial Officer
Apr 12, 2013 01:15AM Algeta ASA : Hilde Furberg and Paolo Pucci elected as new members of Algeta's Board of Directors
Apr 11, 2013 07:30AM Amarantus Announces Preclinical Development Timeline for MANF Therapeutic
Apr 8, 2013 12:05PM Transgene to Present New Data on TG1050 and TG4040 to Treat Chronic Hepatitis B and C at EASL 2013
Apr 8, 2013 09:00AM Surveyed U.S. Neurologists Would Prescribe Biogen Idec's Tecfidera to 20 Percent of Their Patients with Relapsing-Remitting Multiple Sclerosis (RR-MS)
Apr 8, 2013 09:00AM Genzyme’s Once-daily, Oral AUBAGIO® (teriflunomide) Approved in Argentina for the Treatment of Relapsing Multiple Sclerosis
Apr 2, 2013 08:00AM NextBio and Genophen Form Partnership Aimed at Applying Genomics to Personalized Disease Prevention and Wellness
Mar 27, 2013 06:00AM Verastem Reports Year-End 2012 Financial Results
Mar 25, 2013 08:43AM 89 Degrees to Present at Demandware XChange with Clients Fila and Crabtree & Evelyn
Mar 25, 2013 06:11AM Sanofi (SNY), Transgene Enter Long-Term Immunotherapy Development
Mar 25, 2013 02:00AM Sanofi and Transgene Announce Innovative Long-Term Collaboration for the Production of Immunotherapy Treatments
Mar 22, 2013 08:56AM Sanofi's (SNY) Genzyme Receives Positive CHMP AUBAGIO as MS Treatment
Mar 21, 2013 03:09PM Sanofi (SNY) Unit Issues Encouraging Update for First-Year of LEMTRADA Phase III in MS
Feb 5, 2013 01:05AM ZALTRAP® (ziv-aflibercept) Approved in the EU for Patients with Previously Treated Metastatic Colorectal Cancer
Jan 30, 2013 06:37AM Isis (ISIS), Genzyme (SNY) Receive FDA Approval for KYNAMRO NDA
Jan 28, 2013 06:20AM Sanofi's (SNY) Genzyme sBLA for LEMTRADA Accepted by FDA
Jan 7, 2013 07:48AM Alnylam (ALNY) Plans to End 2012 With $225 Million in Cash, Provides Goals
Dec 14, 2012 03:40PM Stocks Crossing 50-Day SMA 12/14: (ISIS) (GOL) (SNE) Above; (QCOM) (ARIA) (PAY) Below
Dec 14, 2012 07:31AM Genzyme (SNY), Isis Pharma (ISIS) Receive Negative Opinion from CHMP Over KYNAMRO
Dec 7, 2012 07:03AM Sanofi's (SNY) Genzyme Receives EC Approval for Thyrogen
Nov 21, 2012 04:03PM Sanofi's (SNY) Genzyme Receives Approval for AUBAGIO in Australia
Oct 22, 2012 06:02AM Alnylam (ALNY), Genzyme (SNY) Enter RNAi Development for ATTR Solution in Asia
View Older Stories